CCIA
RPTP

Campbell & Co Investment Adviser’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Campbell & Co Investment Adviser’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-27,357
Closed -$166K – 353
2015
Q3 		$166K Buy
+27,357
New +$335K 0.11% 283

Other funds holding RPTP

CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Campbell & Co Investment Adviser's RPTP Position: Q4 2015 in Review

Campbell & Co Investment Adviser sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2015, closing a stake of 27,357 shares — an estimated $166K sold.

Campbell & Co Investment Adviser first reported a position in RPTP in Q3 2015 and held it in 1 quarter. The position peaked at $166K in Q3 2015. 108 funds tracked by Wall St. Rank hold RPTP as of Q4 2015.

  • Campbell & Co Investment Adviser reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2015 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 27,357 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2015, an estimated $166K.
  • Campbell & Co Investment Adviser first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q3 2015 and held it in 1 quarter.
  • Campbell & Co Investment Adviser's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $166K in Q3 2015.
  • 108 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2015.

Based on Campbell & Co Investment Adviser's 13F filing for Q4 2015, filed 16 Feb 2016.